Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
clinical trials
fda
2
×
life sciences
national blog main
alexion pharmaceuticals
amyotrophic lateral sclerosis (als)
autoimmune disorders
biotech
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cancer
companion diagnostic
complement system
deals
detroit blog main
detroit top stories
dna sequencing
drugs
entrectinib
express scripts
foundation medicine
generalized myasthenia gravis
immune-mediated necrotizing myopathy
indiana blog main
indiana top stories
josh bilenker
keytruda
larotrectinib
loxo oncology
melanie nallicheri
merck
national
national top stories
new england journal of medicine
new york blog main
new york top stories
What
drug
world
2
×
alternative
approved
autoimmune
cancer
candidate
deal
deeper
disease
dna
expensive
fda
fingerprint
genetic
going
lead
matter
medicine
medicines
nd
new
oks
pharma
pharmaceuticals
potential
ra
second
stakes
targets
territory
time
tissues
tumor's
ucb
viewed
Language
unset
Current search:
world
×
fda
×
" boston blog main "
×
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
